Lorcaserin Extended-Release Tablets and PEG-3350 with Electolytes
Determining the interaction of Lorcaserin Extended-Release Tablets and PEG-3350 with Electolytes and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: polyethylene glycol 3350 with electrolytes
Brand name: Colyte with Flavor Packs, GaviLyte-C, GoLYTELY, MoviPrep, NuLYTELY Orange, NuLYTELY with Flavor Packs, PEG-3350 with Electolytes, Plenvu, TriLyte with Flavor Packs, NuLYTELY, TriLyte, Suclear
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-PEG-3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride
- Lorcaserin Extended-Release Tablets-PEG-Prep and Bisacodyl
- Lorcaserin Extended-Release Tablets-PEG3350
- Lorcaserin Extended-Release Tablets-Pegademase bovine
- Lorcaserin Extended-Release Tablets-Pegademase Bovine Injection
- Lorcaserin Extended-Release Tablets-Pegademase bovine Intramuscular
- PEG-3350 with Electolytes-Lorcaserin Hydrochloride
- PEG-3350 with Electolytes-Lorcaserin Tablets
- PEG-3350 with Electolytes-Lorcet
- PEG-3350 with Electolytes-Lorcet Plus
- PEG-3350 with Electolytes-Lorcet Tablets
- PEG-3350 with Electolytes-Lorlatinib